Evaluation of the Available Variant Calling Tools for Oxford Nanopore Sequencing in Breast Cancer
Open Access
Abstract
The goal of biomarker testing, in the field of personalized medicine, is to guide treatments to achieve the best possible results for each patient. The accurate and reliable identification of everyone’s genome variants is essential for the success of clinical genomics, employing third-generation sequencing. Different variant calling techniques have been used and recommended by both Oxford Nanopore Technologies (ONT) and Nanopore communities. A thorough examination of the variant callers might give critical guidance for third-generation sequencing-based clinical genomics. In this study, two reference genome sample datasets (NA12878) and (NA24385) and the set of high-confidence variant calls provided by the Genome in a Bottle (GIAB) were used to allow the evaluation of the performance of six variant calling tools, including Human-SNP-wf, Clair3, Clair, NanoCaller, Longshot, and Medaka, as an integral step in the in-house variant detection workflow. Out of the six variant callers understudy, Clair3 and Human-SNP-wf that has Clair3 incorporated into it achieved the highest performance rates in comparison to the other variant callers. Evaluation of the results for the tool was expressed in terms of Precision, Recall, and F1-score using Hap.py tools for the comparison. In conclusion, our findings give important insights for identifying accurate variants from third-generation sequencing of personal genomes using different variant detection tools available for long-read sequencing.Keywords
This publication has 49 references indexed in Scilit:
- HapCUT2: robust and accurate haplotype assembly for diverse sequencing technologiesGenome Research, 2016
- WhatsHap: fast and accurate read-based phasingbioRxiv, 2016
- TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencingDiagnostic Pathology, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian CancerThe Journal of Molecular Diagnostics, 2015
- A Comprehensive Focus on Global Spectrum ofBRCA1andBRCA2Mutations in Breast CancerBioMed Research International, 2013
- Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genesEuropean Journal of Human Genetics, 2012
- Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancerChinese Journal of Cancer, 2012
- American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variantsGenetics in Medicine, 2011
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008